<?xml version="1.0" encoding="UTF-8"?>
<ref id="zoi201035r23">
 <label>23</label>
 <mixed-citation publication-type="confproc">
  <person-group>
   <name name-style="western">
    <surname>Basik</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cecchini</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>De Los Santos</surname>
    <given-names>J.</given-names>
   </name>
  </person-group> Abstract GS5-05: primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery. Paper presented at: San Antonio Breast Cancer Symposium; December 13, 
  <year>2019</year>; San Antonio, TX.
 </mixed-citation>
</ref>
